Literature DB >> 30460451

Sez6l2-antibody-associated progressive cerebellar ataxia: a differential diagnosis of atypical parkinsonism.

Max Borsche1,2, Stefanie Hahn3, Henrike Hanssen1,2, Alexander Münchau1, Klaus-Peter Wandinger2,4, Norbert Brüggemann5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30460451     DOI： 10.1007/s00415-018-9115-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Identification of anti-Sez6l2 antibody in a patient with cerebellar ataxia and retinopathy.

Authors:  Hiroaki Yaguchi; Ichiro Yabe; Hidehisa Takahashi; Fumihiko Okumura; Akiko Takeuchi; Kazuhiro Horiuchi; Takahiro Kano; Atsuhiro Kanda; Wataru Saito; Masaki Matsumoto; Keiichi I Nakayama; Shigetsugu Hatakeyama; Hidenao Sasaki
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

2.  Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family.

Authors:  Taisuke Miyazaki; Kouichi Hashimoto; Atsushi Uda; Hiroyuki Sakagami; Yoshitaka Nakamura; Shin-ya Saito; Miyuki Nishi; Hideaki Kume; Akira Tohgo; Izumi Kaneko; Hisatake Kondo; Kohji Fukunaga; Masanobu Kano; Masahiko Watanabe; Hiroshi Takeshima
Journal:  FEBS Lett       Date:  2006-06-27       Impact factor: 4.124

3.  Antibody-associated CNS syndromes without signs of inflammation in the elderly.

Authors:  Domingo Escudero; Mar Guasp; Helena Ariño; Carles Gaig; Eugenia Martínez-Hernández; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2017-09-06       Impact factor: 9.910

4.  Sez6l2 regulates phosphorylation of ADD and neuritogenesis.

Authors:  Hiroaki Yaguchi; Ichiro Yabe; Hidehisa Takahashi; Masashi Watanabe; Taichi Nomura; Takahiro Kano; Masaki Matsumoto; Keiichi I Nakayama; Masahiko Watanabe; Shigetsugu Hatakeyama
Journal:  Biochem Biophys Res Commun       Date:  2017-10-12       Impact factor: 3.575

5.  Clinical manifestations of the anti-IgLON5 disease.

Authors:  Carles Gaig; Francesc Graus; Yarko Compta; Birgit Högl; Luis Bataller; Norbert Brüggemann; Caroline Giordana; Anna Heidbreder; Katya Kotschet; Jan Lewerenz; Stefan Macher; Maria J Martí; Teresa Montojo; Jesus Pérez-Pérez; Inmaculada Puertas; Caspar Seitz; Mateus Simabukuro; Nieves Téllez; Klaus-Peter Wandinger; Alex Iranzo; Guadalupe Ercilla; Lidia Sabater; Joan Santamaría; Josep Dalmau
Journal:  Neurology       Date:  2017-04-05       Impact factor: 9.910

6.  A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study.

Authors:  Lidia Sabater; Carles Gaig; Ellen Gelpi; Luis Bataller; Jan Lewerenz; Estefanía Torres-Vega; Angeles Contreras; Bruno Giometto; Yaroslau Compta; Cristina Embid; Isabel Vilaseca; Alex Iranzo; Joan Santamaría; Josep Dalmau; Francesc Graus
Journal:  Lancet Neurol       Date:  2014-04-03       Impact factor: 44.182

7.  Neuropathological criteria of anti-IgLON5-related tauopathy.

Authors:  Ellen Gelpi; Romana Höftberger; Francesc Graus; Helen Ling; Janice L Holton; Timothy Dawson; Mara Popovic; Janja Pretnar-Oblak; Birgit Högl; Erich Schmutzhard; Werner Poewe; Gerda Ricken; Joan Santamaria; Josep Dalmau; Herbert Budka; Tamas Revesz; Gabor G Kovacs
Journal:  Acta Neuropathol       Date:  2016-06-29       Impact factor: 17.088
  7 in total
  5 in total

1.  Homer-3 Antibody Disease: A Potentially Treatable MSA-C Mimic.

Authors:  Eoin Mulroy; Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2022-01-08

Review 2.  Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.

Authors:  Sergio Muñiz-Castrillo; Alberto Vogrig; Nicolás Lundahl Ciano-Petersen; Macarena Villagrán-García; Bastien Joubert; Jérôme Honnorat
Journal:  Cerebellum       Date:  2022-01-12       Impact factor: 3.648

3.  SEZ6L2 knockdown impairs tumour growth by promoting caspase-dependent apoptosis in colorectal cancer.

Authors:  Ning An; Yaqin Zhao; Haitao Lan; Ming Zhang; Yuan Yin; Cheng Yi
Journal:  J Cell Mol Med       Date:  2020-02-27       Impact factor: 5.310

4.  SEZ6L2 Antibody-Associated Cerebellar Ataxia Responsive to Sequential Immunotherapy.

Authors:  Ayla Mehdiyeva; Aki Hietaharju; Jussi Sipilä
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-01-14

5.  Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects.

Authors:  Jon Landa; Mar Guasp; Mar Petit-Pedrol; Eugenia Martínez-Hernández; Jesús Planagumà; Albert Saiz; Raquel Ruiz-García; Lorena García-Fernández; Jan Verschuuren; Rachel Saunders-Pullman; Liliana Ramirez-Gómez; Michael D Geschwind; Josep Dalmau; Lidia Sabater; Francesc Graus
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.